Is Sempra (SRE) a risky stock?
As of July 21, 2026, Clavix grades Sempra (SRE) B- for risk, a composite score of 76 out of 100 on an A+ to F scale, which puts SRE in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind SRE's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how SRE scores on each, as of July 21, 2026.
What's moving SRE's risk right now
Company-specific signals Clavix flags behind SRE's current grade, drawn from recent news and filings as of July 21, 2026.
Sempra will report second-quarter 2026 results before markets open on August 6, followed by a leadership conference call. Separately, Jennison Associates trimmed its SRE stake by 2.1% in Q1, while Independent Financial Group opened a new position.
The linked reporting describes a methane gas burst at a Teesta Stage VI hydroelectric tunnel run by India's NHPC, killing 10 workers and trapping 25 others. The incident appears unrelated to Sempra's business and would not directly affect SRE.
What a B- grade means
On the Clavix A+ to F scale, SRE's composite of 76 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell SRE or any security. Grades are risk indicators, not predictions of return. Data may be delayed.